Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroreport ; 23(9): 546-50, 2012 Jun 20.
Article in English | MEDLINE | ID: mdl-22525836

ABSTRACT

Chondroitin sulfate proteoglycans are formed in scar tissue after a spinal cord injury and inhibit axon regrowth. The production of neurocan, one of these chondroitin sulfate proteoglycans, in cultured spinal cord astrocytes increased after the addition of epidermal growth factor (EGF) in a dose-dependent manner (2-200 ng/ml). In astrocytes stimulated by 20 ng/ml of EGF, neurocan production was inhibited after the addition of the p38 mitogen-activated protein kinase (MAPK) inhibitor (SB203580: 3-10 µM) in a dose-dependent manner. These results suggest that the activation of p38 MAPK is one of the mechanisms of neurocan production in EGF-stimulated astrocytes. The p38 MAPK inhibitor may reduce neurocan production and accelerate axonal regrowth after a spinal cord injury.


Subject(s)
Astrocytes/metabolism , Neurocan/metabolism , Spinal Cord/metabolism , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , p38 Mitogen-Activated Protein Kinases/metabolism , Animals , Astrocytes/drug effects , Cells, Cultured , Enzyme Inhibitors/pharmacology , Epidermal Growth Factor/pharmacology , Imidazoles/pharmacology , Neurocan/drug effects , Pyridines/pharmacology , Rats , Rats, Wistar , Spinal Cord/drug effects , Spinal Cord Injuries/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...